Search results
Results From The WOW.Com Content Network
The FDA has placed a partial clinical hold on new participant enrollment in Avidity Biosciences Inc's (NASDAQ: RNA) Phase 1/2 MARINA trial of AOC 1001 in adults with myotonic dystrophy type 1 (DM1).
Avidity Biosciences (RNA) reports FDA-imposed partial hold on enrolling new patients in its phase I/II MARINA study evaluating AOC 1001 in myotonic dystrophy type 1 in adults. Stock down.
Avidity. In biochemistry, avidity refers to the accumulated strength of multiple affinities of individual non-covalent binding interactions, such as between a protein receptor and its ligand, and is commonly referred to as functional affinity. Avidity differs from affinity, which describes the strength of a single interaction.
HFS then expanded into other businesses, and, in 1997, merged with CUC International to form Cendant Corporation. [citation needed] In 2005, Cendant bought the Wyndham hotel brand from the Blackstone Group. The Wyndham hotel brand was created in 1981 in Dallas, Texas, by Trammell Crow, the president of Trammell Crow Company.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate; Help; Learn to edit; Community portal; Recent changes; Upload file
Micron , Qualcomm , KLA Corp , and Lam Research also closed at all-time highs on Tuesday, catapulting the broader S&P 500 Tech Index to its own record and bumping up its year-to-date return to an ...
A. Abbott Laboratories; AbbVie; Abgent; Ablitech, Inc. Acceleron Pharma; ACell; Acorda Therapeutics; ACT Biotech Inc; Advaxis; Adverum Biotechnologies; Affymetrix
From January 2008 to December 2012, if you bought shares in companies when Ann M. Fudge joined the board, and sold them when she left, you would have a -43.4 percent return on your investment, compared to a -2.8 percent return from the S&P 500.